Pascal Soriot, AstraZeneca CEO (David Zorrakino/Europa Press via AP)
February 9, 2023 03:39 PM ESTUpdated 04:49 PM
Pharma

As­traZeneca CEO Pas­cal So­ri­ot aims for 15 new drug launch­es by 2030

Nicole DeFeudis

Editor

As­traZeneca CEO Pas­cal So­ri­ot on Thurs­day un­veiled am­bi­tious plans to launch 15 new drugs by 2030 — and he’s wast­ing no time, with 30 Phase III …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times